Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Martha J. Glenn"'
Autor:
Deborah M. Stephens, Ken Boucher, Elizabeth Kander, Sameer A. Parikh, Erin M. Parry, Mazyar Shadman, John M. Pagel, Jennifer Cooperrider, Joanna Rhodes, Anthony Mato, Allison Winter, Brian Hill, Sameh Gaballa, Alexey Danilov, Tycel Phillips, Danielle M. Brander, Sonali M. Smith, Matthew Davids, Kerry Rogers, Martha J. Glenn, John C. Byrd
Publikováno v:
Haematologica, Vol 106, Iss 11 (2020)
Chronic lymphocytic leukemia (CLL) patients who develop Hodgkin lymphoma (HL) have limited survival. No current therapeutic standard of care exists. We conducted a multi-center retrospective study of patients with Hodgkin transformation (HT) of CLL.
Externí odkaz:
https://doaj.org/article/0260f2bf0b3e47f7bd3285461f73f519
Autor:
Tibor J. Kovacsovics, Alice Mims, Mohamed E. Salama, Jeremy Pantin, Narayanam Rao, Ken M. Kosak, Peter Ahorukomeye, Martha J. Glenn, Michael W.N. Deininger, Kenneth M. Boucher, Linda M. Bavisotto, Gerardo Gutierrez-Sanchez, Thomas P. Kennedy, Stephen G. Marcus, Paul J. Shami
Publikováno v:
Blood Advances, Vol 2, Iss 4, Pp 381-389 (2018)
Abstract: Relapses in acute myelogenous leukemia (AML) are a result of quiescent leukemic stem cells (LSCs) in marrow stromal niches, where they resist chemotherapy. LSCs employ CXCL12/CXCR4 to home toward protective marrow niches. Heparin disrupts C
Externí odkaz:
https://doaj.org/article/d8c9e5b72fa24e22bf5702f2b9d31251
Autor:
Randa Tao, Yuji Chen, Seungmin Kim, Krista Ocier, Shane Lloyd, Matthew M. Poppe, Catherine J. Lee, Martha J. Glenn, Ken R. Smith, Alison Fraser, Vikrant Deshmukh, Michael G. Newman, John Snyder, Kerry G. Rowe, David K. Gaffney, Ben Haaland, Mia Hashibe
Publikováno v:
Cancer. 128:3564-3572
Long-term mental health outcomes were characterized in patients who were diagnosed with Hodgkin lymphoma (HL), and risk factors for the development of mental health disorders were identified.Patients who were diagnosed with HL between 1997 and 2014 w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3df6fe5523a0356a65e533996ef087f9
https://doi.org/10.1002/cncr.34359
https://doi.org/10.1002/cncr.34359
Autor:
Andrew D, Zelenetz, Leo I, Gordon, Julie E, Chang, Beth, Christian, Jeremy S, Abramson, Ranjana H, Advani, Nancy L, Bartlett, L Elizabeth, Budde, Paolo F, Caimi, Sven, De Vos, Bhagirathbhai, Dholaria, Bita, Fakhri, Luis E, Fayad, Martha J, Glenn, Thomas M, Habermann, Francisco, Hernandez-Ilizaliturri, Eric, Hsi, Boyu, Hu, Mark S, Kaminski, Christopher R, Kelsey, Nadia, Khan, Susan, Krivacic, Ann S, LaCasce, Megan, Lim, Mayur, Narkhede, Rachel, Rabinovitch, Praveen, Ramakrishnan, Erin, Reid, Kenneth B, Roberts, Hayder, Saeed, Stephen D, Smith, Jakub, Svoboda, Lode J, Swinnen, Joseph, Tuscano, Julie M, Vose, Mary A, Dwyer, Hema, Sundar
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 19(11)
In the last decade, a better understanding of the molecular pathogenesis of B-cell non-Hodgkin lymphomas has resulted in the development of novel targeted therapies, such as small molecule inhibitors of select kinases in the B-cell receptor pathway,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::46dab11e87ac3e8835733749b4e3c203
https://pubmed.ncbi.nlm.nih.gov/34781267
https://pubmed.ncbi.nlm.nih.gov/34781267
Publikováno v:
Cancer. 101:1275-1282
BACKGROUND Women with Hodgkin disease (HD) who received mantle irradiation had an increased risk of developing breast carcinoma. The authors examined the influence of radiotherapy on the time interval to the development of breast carcinoma. METHODS U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3af9da8ec85f7f1517e6d749cb954697
https://doi.org/10.1002/cncr.20516
https://doi.org/10.1002/cncr.20516
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics. 6(1)
Purpose: To investigate a simplified panel of fluorescent in-situ hybridization (FISH) probes for evaluation of patients with chronic lymphocytic leukemia (CLL) and to correlate results from this technique with known prognostic factors. Methods: We r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::443f4bfe92d3a2cc149bb58da0308efb
https://pubmed.ncbi.nlm.nih.gov/14726809
https://pubmed.ncbi.nlm.nih.gov/14726809